InterVenn Biosciences to Present at Bank of America 2022 Healthcare Conference


SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn Biosciences, the leader in glycoproteomics, today announced that Aldo Carrascoso, Co-Founder and CEO, will present at the Bank of America 2022 Healthcare Conference on Tuesday, May 10, 2022 in Las Vegas, NV.

Bank of America 2022 Healthcare Conference

Date: Tuesday, May 10, 2022

Time: 2:00 p.m. PT / 5:00 p.m. ET

Location: Las Vegas, Nevada

Format: formal presentation and 1×1

A live webcast of the event will be available in the “For Investors” section of the InterVenn website at A replay will be available for 90 days after the event.

About InterVenn Biosciences

InterVenn is a clinical technology company that uses AI-powered software to unlock the value of glycoproteomics for the development of transformational healthcare solutions. The glycoproteome is a source of vital information about human biology that has the potential to dramatically improve patient outcomes, yet it has remained inaccessible due to its high complexity. InterVenn is pioneering a new AI-powered platform to decode and unlock the potential of the glycoproteome at a clinically meaningful scale for the first time in history. To optimize this whole new dimension of biology, the company has developed a platform capable of producing a robust pipeline of powerful clinical applications, ranging from early detection of diseases to diagnosis and potentially to therapeutics. InterVenn will help make the new era of personalized, predictive and preventative care a reality. For more information about InterVenn, visit


Comments are closed.